Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis (Q61451061)

primary sclerosing cholangitis

inferred from title

1 reference

inflammatory bowel diseases

inferred from title

1 reference

Fotios S Fousekis

1

0 references

Vasileios I Theopistos

2

0 references

Ioannis V Mitselos

3

0 references

Alexandros Skamnelos

4

0 references

Athanasios Kavvadias

5

0 references

Konstantinos H Katsanos

6

0 references

Dimitrios K Christodoulou

Journal of Clinical Medicine Research

7

0 references

language of work or name

English

0 references

publication date

February 2019

0 references

published in

0 references

volume

11

0 references

issue

2

0 references

page(s)

81-88

0 references

cites work

Surgical aspects of sclerosing cholangitis. Results in 178 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis in Japan--analysis of 192 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Recurrence of diseases following orthotopic liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Abnormal Hepatic Biochemistries in Patients With Inflammatory Bowel Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis--what is the difference between east and west?

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Crohn's disease of the ileal pouch: reality, diagnosis, and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

High lifetime risk of cancer in primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Diagnosis and management of primary sclerosing cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Liver disorders in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The presence of primary sclerosing cholangitis is protective for ileal pouch from Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

ACG Clinical Guideline: Primary Sclerosing Cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Extraintestinal Manifestations of Inflammatory Bowel Disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Risk factors for recurrent primary sclerosing cholangitis after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory pouch disease: The spectrum of pouchitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis associated with inflammatory bowel disease: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

A review of the medical treatment of primary sclerosing cholangitis in the 21st century

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Letter: vedolizumab for the management of inflammatory bowel disease in patients after liver transplantation for primary sclerosing cholangitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Pathogenesis and clinical spectrum of primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Safety of anti-TNF treatment in liver transplant recipients- a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: Review of general recommendations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Secondary Sclerosing Cholangitis: a Review of Recent Literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Safety and Efficacy of Biologic Agents for the Management of Inflammatory Bowel Disease After Liver Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Endoscopic Management of Primary Sclerosing Cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

The IBD and PSC Phenotypes of PSC-IBD

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

[Primary sclerosing cholangitis : Current diagnostics and treatment]

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Primary sclerosing cholangitis: A review and update

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020

Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30700999

12 December 2020